KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Change in Intangibles: 2017-2025

Historic Change in Intangibles for Biomarin Pharmaceutical (BMRN) over the last 6 years, with Sep 2025 value amounting to $5.3 million.

  • Biomarin Pharmaceutical's Change in Intangibles rose 95.47% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year decrease of 52.37%. This contributed to the annual value of $12.0 million for FY2024, which is 9.84% up from last year.
  • Biomarin Pharmaceutical's Change in Intangibles amounted to $5.3 million in Q3 2025, which was up 1,893.61% from $266,000 recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Change in Intangibles registered a high of $15.6 million during Q4 2021, and its lowest value of $266,000 during Q2 2025.
  • Over the past 3 years, Biomarin Pharmaceutical's median Change in Intangibles value was $1.4 million (recorded in 2023), while the average stood at $2.8 million.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Change in Intangibles tumbled by 95.70% in 2022, and later surged by 2,480.65% in 2024.
  • Biomarin Pharmaceutical's Change in Intangibles (Quarterly) stood at $15.6 million in 2021, then crashed by 95.70% to $671,000 in 2022, then surged by 1,059.31% to $7.8 million in 2023, then slumped by 90.11% to $769,000 in 2024, then soared by 95.47% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $266,000 for Q2 2025, and $769,000 during Q4 2024.